Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer
The aim of the study is to determine if Iressa added to chemotherapy with Irinotecan, 5Fluorouracil and Leucovorin can prolong the period of time without any disease worsening (Time to Progression) in patients with metastatic colorectal cancer.
Metastatic Colorectal Cancer
DRUG: Iressa (Gefitinib)|DRUG: Irinotecan|DRUG: 5Fluorouracil|DRUG: Leucovorin
Time to progression (6 months after Last patient in)
Objective Response Rate, Duration of Response, Disease control rate, Overall Survival, (6 months after Last patient in)
The aim of the study is to determine if Iressa added to chemotherapy with Irinotecan, 5Fluorouracil and Leucovorin can prolong the period of time without any disease worsening (Time to Progression) in patients with metastatic colorectal cancer.